Related Experiment Videos
Apoptosis in metabolic myopathies
M C Monici1, A Toscano, P Girlanda
1Institute of Neurological and Neurosurgical Sciences, Policlinico Universitario, Messina, Italy.
Neuroreport
|August 7, 1998
Summary
Apoptosis, or programmed cell death, occurs in skeletal muscles of patients with mitochondrial myopathies. This programmed cell death is linked to mitochondrial dysfunction and may involve specific proteins.
Area of Science:
- Cell Biology
- Biochemistry
- Neurology
Background:
- DNA fragmentation, a key indicator of apoptosis, has yielded conflicting results in skeletal muscle disorders.
- The relationship between apoptosis and mitochondria is complex and warrants further investigation.
Purpose of the Study:
- To investigate the occurrence of apoptosis in skeletal muscles of patients with mitochondrial respiratory chain defects and metabolic myopathies.
- To explore the link between mitochondrial dysfunction and apoptosis in these conditions.
Main Methods:
- Utilized in situ labeling techniques to detect nuclear DNA fragmentation in muscle tissue.
- Analyzed muscle samples from patients diagnosed with mitochondrial myopathies and multiple acyl-CoA dehydrogenase deficiency.
Main Results:
- A significant proportion of apoptotic myonuclei were identified in all 10 patients with mitochondrial myopathies.
- Apoptotic myonuclei were also observed in a patient with multiple acyl-CoA dehydrogenase deficiency, a condition affecting mitochondrial metabolism.
- Findings suggest a correlation between mitochondrial defects and programmed cell death in skeletal muscles.
Conclusions:
- Apoptosis is present in skeletal muscles affected by mitochondrial myopathies and related metabolic disorders.
- Mitochondrial dysfunction plays a critical role in the apoptotic process within muscle cells.
- Further research into the mitochondrial role in apoptosis may reveal therapeutic targets for metabolic myopathies.